IL13 and systemic sclerosis: Effector CD8+ T cells from patients with SSc have been shown to exhibit strong cytotoxicity and produce excessive amounts of profibrotic interleukin-13 (IL-13) and subsequently lead to more severe forms of cutaneous fibrosis [40].